Do the cholesterol-lowering properties of statins affect cancer risk?

This publication has 84 references indexed in Scilit:

• Risk factors for prostate cancer incidence and progression in the health professionals follow‐up study
  International Journal of Cancer, 2007
• Stromal and Epithelial Caveolin-1 Both Confer a Protective Effect Against Mammary Hyperplasia and Tumorigenesis: Caveolin-1 Antagonizes Cyclin D1 Function in Mammary Epithelial Cells
  The American Journal of Pathology, 2006
• Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes
  Proceedings of the National Academy of Sciences, 2003
• The Pleiotropic Effects of HMG-CoA Reductase Inhibitors
  Drugs, 2003
• Pitavastatin Enhanced BMP-2 and Osteocalcin Expression by Inhibition of Rho-Associated Kinase in Human Osteoblasts
  Biochemical and Biophysical Research Communications, 2001
• Cholesterol Depletion Disrupts Caveolae and Insulin Receptor Signaling for Metabolic Control via Insulin Receptor Substrate-1, but Not for Mitogen-activated Protein Kinase Control
  Journal of Biological Chemistry, 2001
• Clinical Pharmacokinetics of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors
  Clinical Pharmacokinetics, 1996
• Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
• Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
• Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo
  Biochemical and Biophysical Research Communications, 1989